These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 37861542)
1. Mechanism of Liuwei Dihuang Pills in treating osteoporosis based on network pharmacology. Wang X; Li H; Long L; Song C; Chen R; Pan H; Qiu J; Liu B; Liu Z Medicine (Baltimore); 2023 Oct; 102(42):e34773. PubMed ID: 37861542 [TBL] [Abstract][Full Text] [Related]
2. Prediction of network pharmacology and molecular docking-based strategy to determine potential pharmacological mechanism of Liuwei Dihuang pill against tinnitus. Wu Z; Zhu Z; Cao J; Wu W; Hu S; Deng C; Xie Q; Huang X; You C Medicine (Baltimore); 2022 Nov; 101(46):e31711. PubMed ID: 36401375 [TBL] [Abstract][Full Text] [Related]
3. Network pharmacology and molecular docking approach to elucidate the mechanisms of Liuwei Dihuang pill in diabetic osteoporosis. Lu Z; Huang M; Lin H; Wang G; Li H J Orthop Surg Res; 2022 Jun; 17(1):314. PubMed ID: 35701780 [TBL] [Abstract][Full Text] [Related]
4. A network pharmacological-based study of the mechanism of Liuwei Dihuang pill in the treatment of chronic kidney disease. Xie X; Lou H; Shi Y; Gan G; Deng H; Ma X; Meng M; Gao X Medicine (Baltimore); 2023 May; 102(19):e33727. PubMed ID: 37171332 [TBL] [Abstract][Full Text] [Related]
5. Uncovering the Key miRNAs and Targets of the Liuwei Dihuang Pill in Diabetic Nephropathy-Related Osteoporosis based on Weighted Gene Co-Expression Network and Network Pharmacology Analysis. Liu MM; Lv NN; Geng R; Hua Z; Ma Y; Huang GC; Cheng J; Xu HY Endocr Metab Immune Disord Drug Targets; 2022; 22(3):274-289. PubMed ID: 33588742 [TBL] [Abstract][Full Text] [Related]
6. Study on the Mechanism of Liuwei Dihuang Pills in Treating Parkinson's Disease Based on Network Pharmacology. Lin D; Zeng Y; Tang D; Cai Y Biomed Res Int; 2021; 2021():4490081. PubMed ID: 34746302 [TBL] [Abstract][Full Text] [Related]
7. Study on the mechanism of Qiju Dihuang pill in the treatment of ophthalmic diseases based on systems pharmacology. Liu F; Tian M Medicine (Baltimore); 2022 Aug; 101(31):e30033. PubMed ID: 35945711 [TBL] [Abstract][Full Text] [Related]
8. [Mechanism of Liangfu Pills in treatment of functional dyspepsia: based on network pharmacology and experimental verification]. He JY; Gui B; Chen YF; Yin YQ; Tao SH; Shen ZB; Li KP; Fu JB; Wei L Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(14):3853-3862. PubMed ID: 35850844 [TBL] [Abstract][Full Text] [Related]
9. A Network Pharmacology-Based Strategy For Predicting Active Ingredients And Potential Targets Of LiuWei DiHuang Pill In Treating Type 2 Diabetes Mellitus. He D; Huang JH; Zhang ZY; Du Q; Peng WJ; Yu R; Zhang SF; Zhang SH; Qin YH Drug Des Devel Ther; 2019; 13():3989-4005. PubMed ID: 31819371 [TBL] [Abstract][Full Text] [Related]
10. Investigation of the Underlying Mechanism of Zhibai Dihuang Pill in Treating Osteoporosis by using Network Pharmacology and Molecular Dynamics Simulation. Feng Y; Zhang L; Zhao C; Li N; Chang B Endocr Metab Immune Disord Drug Targets; 2023; 23(9):1201-1214. PubMed ID: 36518044 [TBL] [Abstract][Full Text] [Related]
11. Using Network Pharmacology and Molecular Docking to Explore the Mechanism of Qiju Dihuang Pill against Dry Eye Disease. Zhao X; Yu Z; Li D; Duan J Comput Math Methods Med; 2022; 2022():7316794. PubMed ID: 36590763 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of Liuwei Dihuang pill against KDM7A and Wnt/β-catenin signaling pathway in diabetic nephropathy-related osteoporosis. Liu MM; Dong R; Hua Z; Lv NN; Ma Y; Huang GC; Cheng J; Xu HY Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32914833 [TBL] [Abstract][Full Text] [Related]
13. Research progress on classical traditional Chinese medicine formula Liuwei Dihuang pills in the treatment of type 2 diabetes. Zheng W; Wang G; Zhang Z; Wang Z; Ma K Biomed Pharmacother; 2020 Jan; 121():109564. PubMed ID: 31683180 [TBL] [Abstract][Full Text] [Related]
14. Liuwei Dihuang Pills Enhance Osteogenic Differentiation in MC3T3-E1 Cells through the Activation of the Wnt/β-Catenin Signaling Pathway. Zhao J; Liang G; Yang J; Huang H; Dou Y; Gu Z; Liu J; Zeng L; Yang W Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38256932 [TBL] [Abstract][Full Text] [Related]
15. The effects of Liuwei Dihuang on canonical Wnt/β-catenin signaling pathway in osteoporosis. Xia B; Xu B; Sun Y; Xiao L; Pan J; Jin H; Tong P J Ethnopharmacol; 2014 Apr; 153(1):133-41. PubMed ID: 24530448 [TBL] [Abstract][Full Text] [Related]
16. Network Pharmacology and Experimental Validation to Reveal the Pharmacological Mechanisms of Liuwei Dihuang Decoction Against Intervertebral Disc Degeneration. Zhang H; Yao S; Zhang Z; Zhou C; Fu F; Bian Y; Luo H; Li Y; Yan S; Ge Y; Chen Y; Zhan K; Ge Y; Chen Z; Yue M; Li X; Du W; Jin H; Tong P; Ruan H; Wu C Drug Des Devel Ther; 2021; 15():4911-4924. PubMed ID: 34880601 [TBL] [Abstract][Full Text] [Related]
17. [Structure characteristics and quality control of Liuwei Dihuang Concentrated Pill from different manufacturers]. Xia YQ; Li R; Gao S; Cao SM; Feng L; Jia XB Zhongguo Zhong Yao Za Zhi; 2020 Jul; 45(14):3369-3378. PubMed ID: 32726052 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation and analysis of high-quality products of Liuwei Dihuang Pills]. Liu Y; Zhao AY; Ni FY; Yu HC; Cheng JT; DI JP; Liu YZ; Wang ZG; Liu A Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(5):1194-1201. PubMed ID: 32237465 [TBL] [Abstract][Full Text] [Related]
19. [Analysis of Wumei Pills in treating chronic digestive system diseases with concept of "treating different diseases with same method" based on network pharmacology and molecular docking]. Ding J; Zheng P; Sun YY; Wang XR; Feng YC Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(15):4164-4176. PubMed ID: 36046907 [TBL] [Abstract][Full Text] [Related]
20. [Rapid screening of anti-osteoporosis active ingredients from Liuwei Dihuang Decoction by osteoblast membrane chromatography/ultra-high performance liquid chromatography-time of flight mass spectrometry]. Wu C; Xu P; Yao W; Shou D; Zhu Y; Wang N Se Pu; 2019 Mar; 37(3):305-312. PubMed ID: 30900860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]